Abstract: The present invention pertains to a radiation-curable white inkjet ink and, more particularly, to a radiation-curable inkjet white ink comprising a specified titanium dioxide with at least two dispersants. The first is an acidic polyester dispersant and the second is an acrylic structured copolymer dispersant. Ink sets containing the white inks are also described.

Abstract: The present invention pertains to an aqueous inkjet ink made from certain aqueous titanium dioxide slurries, and an associated inkjet ink set for inkjet printing. The invention also pertains to a method of inkjet printing with the ink and ink set. The use of the specific titanium dioxide slurries described herein result in inkjet inks having improved stability and better anti-settling performance with less pigment agglomeration and flocculation over time.

Abstract: Novel compounds of structural formula (I) are disclosed. As modulators of the Cannabinoid-1 (CB1) receptor, these compounds are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. As such, compounds of the present invention are useful as in the treatment, prevention and suppression of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders (e.g., multiple sclerosis, Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis), cerebral vascular accidents, head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, particularly to opiates, alcohol, and nicotine.